chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Upon 3 days of receiving my first vaccine I began to experience very mild and random chest pain. This continued until my second dose of the Moderna vaccine. The day following my second dose,  8/23/21 I  experienced the ?common? side effects low grade fever, drowsiness, blah type feeling, described after the second dose.  My minor chest pain was still relevant as well. On Saturday 8/28, I woke with a fever of 102.7 degrees Fahrenheit . I also had extreme chest pain across my entire chest coupled with abdominal pain. The chest pain was a very sharp aching type of pain. Approximately 6/10. The abdominal pain was the feeling of having the flu and being Ill Approximately 4/10.  There was a couple of times throughout that day that I thought in my head, I feel like I might die.  I felt like this from the time I woke up around 7:00a until approximately 7:00p. My symptoms then began to subside.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 30-AUG-2016, the patient was vaccinated with incorrectly stored dose (wistar ra 27-3) M-M-R II lot # L026553, therapy type was not specified (dose and route of administration were not reported). This is one of several reports received from the same source. Additional information has been requested.
Nausea, then neck tightness,lightheadeded, hypersalivation Then patient developed shakiness, chills and questionable very mild lacy rash to arms
PCV vaccine. Swelling and redness at injection sight. Warm at injection site. Fever of 101.3 for three days, then a lower fever for another three days.
sinus infection; This is a spontaneous report from a Pfizer-sponsored program . A contactable Consumer reported for his wife, that the patient had received first dose of BNT162B2 (COMIRNATY, Formulation: Solution for injection, Lot Number: unknown) on an unspecified date via an unspecified route of administration and for covid-19 immunization (Age at vaccination: unknown). The patient's medical history and concomitant medications was not reported. On an unspecified date the patient experienced sinus and had received unspecified antibiotic as treatment. It was reported that the patient was scheduled for her second COVID shot tomorrow. Outcome of event was unknown.   Information on the lot/batch number has been requested.
todays her temperature is 99. Wondering if that a normal side effect; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer reported for a female patient (wife). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration, on an unspecified date as dose 1, single for Covid-19 immunisation. Patients medical history and concomitant medications were not reported. Reporter said wifes temperature is normally 97, todays her temperature was 99. He was wondering if that was a normal side effect. Advised to reach out to HCP. The patient underwent lab test which included body temperature measurement, results as 99 on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Drug ineffective; Suspected COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Drug ineffective "; SUSPECTED COVID-19 (medically significant), outcome "unknown". Clinical course: After initial dose, the patient and his wife both got COVID.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300072700 same reporter/drug, different patient/event;
and still complaining of pain and inflammation at the injection site; And still complaining of pain and inflammation at the injection site; Swelling at the injection site; she could put a "gel on it for bruising and swelling. She is wondering if she can smear some of that on the site; She has a lot of joint pain; This is a spontaneous report from a contactable consumer (patient's friend) via medical information team. A female patient in her 50's received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), second dose via an unspecified route of administration on an unspecified date as a Single Dose for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Historical vaccination included previously received dose 1 bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), first dose via an unspecified route of administration on an unspecified date, as a single dose for COVID-19 immunization. Report is not related to a study or programme. It was reported that the reporter called on the behalf of her "dear friend who is a female in her 50s". The reporter stated that the patient received the 2nd dose of the Pfizer vaccine on Thursday, and she spoke to her this morning and she still complaining of pain and inflammation at the injection site. The patient has been using cold compress. The reporter stated it was strange because she has been applying a cold compress to lessen the pain and inflammation, but as soon as she stops, it comes back, and it does not even seem to go away. The reporter wanted to know how long the patient would "have to go through this." The reporter stated that the patient was reluctant to call, she says she does not like to call about "every little thing" however the reporter stated its "not a little of a thing" and wanted to call and see if she could help provide answers to her friend. The reporter would like to know if there was anything the patient can use for the pain and swelling at the injection site. She stated she was unsure if she could put a "gel on it for" bruising and swelling. She was wondering if she can smear some of that on the site. The reporter was sure the patient had it because the patient had a lot of joint pain. Maybe with that would alleviate it in addition to the cold compress. That could probably help her. "Advised caller Pfizer does not provide any recommendations regarding the management or treatment of potential adverse events/reactions/symptoms that a patient/consumer may experience". The events were treated with cold compress. The outcome of the events vaccination site pain and vaccination site Inflammation was reported as not recovered and for other events reported as unknown.  No follow-up attempts are possible. No further information is expected.
Hives all over body, they show up on random areas throughout the day, extremely itchy and become painful when itched too much. Itchiness started in scalp/neck. It has been 1 week since the start of the hives/itchiness and they have not gotten better. Only able to be controlled by Benedryl, Allegra, Corizone 10. Just started Prednisone today, 20mg tabs x 2 per day for one week, as prescribed by Urgent Care.
Same day (1/5/2020): tenderness, swelling, throbbing pain at the injection site (left upper arm); difficulty raising arm completely within 3-4 hours post-injection  Next day (1/6/2020): slight tenderness at the injection site, dizziness  Next day (1/7/2020): slight fever, chills, nausea, severe headache; no tenderness at the injection site  Next day (1/8/2020): no fever, chills, nausea, headage; some dizziness and small rash on lower left arm/wrist area  Next day (1/9/2020): no more rash
This case was reported by a pharmacist via call center representative and described the occurrence of erythematous rash in a 64-year-old female patient who received SHINGRIX (batch number ZN22Z, expiry date 2nd February 2021) for prophylaxis. On 13th July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 15th July 2018, 2 days after receiving SHINGRIX, the patient experienced erythematous rash, burning skin and itchy rash. On an unknown date, the outcome of the erythematous rash, burning skin and itchy rash were not recovered/not resolved. It was unknown if the reporter considered the erythematous rash, burning skin and itchy rash to be related to SHINGRIX. Additional details were reported as follows: The patient experienced red, itchy, burning rash on her neck, stomach and chest. The pharmacist was referred to the patient's physician for treatment recommendations.
pt recv vax 27AUG97 & 28AUg97 c/o constant sharp lt jaw pain which radiated into the rt jaw by 29AUG97;pain ended 30AUG97;28SEP97 pt c/o lt jaw pain that had radiated to rt jaw by 29SEP97;
Narrative:  Patient felt faint following administration of Janssen covid vaccine. Patient fell to one knee, their blood glucose was checked and found to be normal. They were given some juice and observed for about 15 minutes. The patient did not improve and was taken to the emergency department for further evaluation.
Employee received Hepatitis B vaccine (2nd dose) at approx. 2:15 pm and went to work. The patient reported feeling nausea and blurry vision at approx. 3:45 pm. Temp. prior to vaccine was 99.1 degree F. Temp. at 3:50 pm was 98. 2 degrees F. Pulse = 79, B/P = 161/100. Employee stopped working and rested for about 30 mins. and went back to work. Employee stated she had not eaten prior to coming to work at 2:00 pm. Employee stated had not eaten since 10:30 pm last night. Employee denies illness or being pregnant and prior vaccine.
Expired Havrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-month-old female patient who received HAV (Havrix) (batch number LY35X, expiry date 16th February 2023) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 24-Feb-2023 Reporter's Comments: A medical assistant called in to report the administration of an expired Havrix dose to a 19-month-old female patient.  The reporter asked if the patient had to be re vaccinated. Additional Supportive Information: The patient was administered with Havrix vaccine, which was already expired, which led to expired vaccine used.
Pt recv vax on 4/9/99; on 4/10/99 pt exp cold sweat, pale, short of breath, weak, headache, limp body; tx=Benadryl, Prednisone
Shingrix / were stored in the freezer / patient received one; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 4B53D, expiry date 10th October 2022) and (batch number 97Y5D, expiry date unknown) for prophylaxis.   In March 2021, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional information was provided as follows: The age at vaccination was not reported but could be 51 or 52 years. The reporter stated that, the vaccine was stored in the freezer due a confusion with Merck's vaccines which led to incorrect storage of drug. The patient received one dose of Shingrix a month ago. The reporter consented to follow up. As per sales data sheet reported batch number for adjuvant was changed from 97YFD to 97Y5D.
Signs/symptoms of the flu, not mild. 18 hours of fever, shakes, pain in head, neck, jaw, back and joints.
Allergic reaction body part affected: arm - right. Where I got my flu shot on 10/8/10. The next day my right arm was hot, red, swollen and very sore. It developed a cellulitis. On 10/10/10 I went to the ER to get it looked at and obtained an order for clindamycin and prednisone.
Very sore arm afternoon and night after shot. Arm was weak and extreme pain in shoulder when moving and lifting following morning.  Took Aleve for pain.  Did not get better.  Went to doctor on 12/8. Was prescribed diclofenac 75mg tablets.  Said to call back if not better after taking meds and would refer to physical therapist.  Pain returned just as severe after completed meds. Called for referral.  Had first appointment with physical therapist on 1/19/16.
Back pain that progressed to numbness and paresthesia starting 01/02/22, developed sensory ataxia, ophthalmoplegia, and areflexia. Suspect Guillain Barre Syndrome based on CSF sample. Patient received IVIG for 5 days. Symptoms improved compared to initial onset of symptoms. However, there are still facial nerve weakness as well as numbness
0.1 mL of Jynneos administered intradermally; 17 year old patient received Jynneos vaccine; Case reference number US-BN-2022-004542 is a spontaneous case report initially received on 04-Nov-2022 from other health professional via Communication (reference number: USBAV22-1862) and concerns a 17-year-old male patient.  The patient's medical history and concomitant medication details were not provided.  On 24-Sep-2022, the patient was vaccinated with the first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00003), at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. As reported, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (explicitly coded as 'intradermal injection' and 'inappropriate age at vaccine administration').  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination.  Additional information received on 07-Nov-2022 from included the local ID number.  This case is linked to case US-BN-2022-004544 (same reporter).; Reporter's Comments: A 17-year-old male patient was vaccinated with the first dose of Jynneos, at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. Reportedly, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (considered as intradermal injection and inappropriate age at vaccine administration). Injection and product administered to patient of inappropriate age are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not provided. Injection and product administered to patient of inappropriate age are both assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 17-year-old male patient was vaccinated with the first dose of Jynneos, at dose reported as 0,1 mL administered intradermally at an unknown site, for monkeypox prophylaxis. Reportedly, the patient was vaccinated with an adult dosage but since the patient was a minor, the smaller dose of vaccine 0,1 mL instead of 0,5 mL was administered intradermally (considered as intradermal injection and inappropriate age at vaccine administration). Injection and product administered to patient of inappropriate age are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not provided. Injection and product administered to patient of inappropriate age are both assessed as not related to suspect product but to human factor. The case is non-serious.
Male with a history of alcoholic cirrhosis, continued ETOH use, MDD, anxiety, and intracranial meningioma presents for evaluation of dyspnea. Patient reports 3 days ago he began to experience dyspnea and non-productive cough with activity as well as subjective fever, chills, headache, sore throat, loose stools, and body aches. He denies any chest pain or abdominal pain at this time. These symptoms have all been relatively constant through the past 3 days, but this morning, patient developed new onset of nausea and vomiting. This coupled with the persistence of his other symptoms prompted him to present to the ED for evaluation. In the ED he was found to be hypoxic but stable. He was placed on 2L nasal cannula with  improvement of his SATS. His labs were significant for WBC 7.2, Procal 0.22, D-Dimer 457, bili 2.1, AST 230, ALT 64, Cr 0.6. A CXR was significant for atelectasis at the bilateral lung bases but no consolidation. Patient is vaccinated x 2 with Pfizer vaccine.
c/o pain in her arm and also a magnet was sticking to her arm.; c/o pain in her arm and also a magnet was sticking to her arm./there's the magnet that get stuck into my arm where the injection site is.; This is a spontaneous report from a contactable consumer (patient).  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on 14Jul2021 as dose 1, single for covid-19 immunization. Patient had no known allergies and no relevant medical history. The patient concomitant medications were not reported. The patient received her 1st Pfizer vaccine dose today (details unspecified) and she had pain in her arm and also a magnet was sticking to her arm. Her arm just happened to be like getting scanned and arm got scanned on the scanner and there was the magnet that got stuck into her arm where the injection site was (Dates was unspecified to unspecified). Today she got her first dose of Pfizer vaccine and she came back home and she went to (name-withheld) and bought some stuff. When she was at (name-withheld) she was checking price some stuff at the little scanner thing and moved her arm where the injection site was she did not mean to and it scan her arm, all the other stuff was in her cart, there was nothing in her hand. She moved to go get one of her item and her arm just happened to be like getting scanned and her arm got scanned on the scanner. The outcome of events was unknown.   The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow-up.
Rash spread from injection site on left arm to shoulder and back. Lasted a 3-4 days and although it itched did not take Benadryl.
I developed pain and swelling in my right inner calf on around 11/27/2021. I checked into the Hospital ER on 12/01/2021 concerned about the unusual and unexplained pain. An ultrasound scan resulted in a diagnosis of thrombophlebitis and was release with orders to treat with warm compress and NSAIDs for swelling. Over the next week the pain and swelling migrated up my inner right thigh. A followup ultrasound scan determined that I had developed a serious deep vein thrombosis (DVT) in my right leg. I was treated with an injection of Heparin, and setup with a 3-month course of Elequis, which I am currently in the process of completing.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Mild, Additional Details: patient passed out 3 times after giving the vaccine i checked her blood pressure and it was 92/62 i lift up her legs and offerd her the epipen but she refused.her parents tried to convience her to get epipen but she also refused.she spent about half hour in the store and she became good and went to home. i called her after 1 hour and she was fine
I have pictures I can upload. She had severe hives - flat, red rash on legs and arms. Very itchy; swollen ankles and swollen wrists and hands. She could barely  move her feet they were so swollen. That happened within 12 hours. And at the doctor's appt online, she said to give her a double dose an antihistamine - I think it was Zyrtec - and Benadryl at night and to be on Cortosteriod cream on the swollen parts. We did that for about three or four days until it was bearable and it stopped. About three days after it stopped  and she wasn't taking meds she had another break out - it almost looked  more like blisters - on torso and on arm. We did the same treatment with meds and cream and it went away within 24 hours. I showed to Pharmacist and the Pharmacist said to give an extra week for the next dose of vaccine to give body a chance to rest.
VERY SORE, SWELLING  HARD AROUND INJECTION SITE DEVELOPED DAY OF VACCINE,   ITCHING DEVELOPED COUPLE DAYS DEVELOPED 4 DAYS AFTER VACCINE AND HAS CONTINUED, RASH IS DEVELOPING
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-395985 (Patient Link).
angioedema face and hands, rash, fever, chills, fatigue, started menstruation all started about 7 hours post vaccination.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium
Pt had facial paralysis on one side of face.  Pt reporting right side of face was drooping.
COAGULOPATHY, UNSPECIFIED TYPE 2/6/2023 RENAL MASS COAGULOPATHY, UNSPECIFIED TYPE 2/6/2023 ENDOCARDITIS COAGULOPATHY, UNSPECIFIED TYPE 2/6/2023 ENDOCARDITIS COAGULOPATHY, UNSPECIFIED TYPE 2/6/2023 ANEMIA COAGULOPATHY, UNSPECIFIED TYPE 2/6/2023 PNEUMOPERITONEUM
Information has been received from a licensed practical nurse concerning a male who was vaccinated with a 0.5mL dose of hepatitis A virus vaccine inactivated (Lot unavailable). The patient developed hives. Unspecified medical attention was sought. The patient's recovery status is unknown. No product quality complaint reported. Additional information has been requested.
Initial misuse report received from a healthcare professional on 28 October 2013. The case were received on 21 March 2014 at GPV. A 58 year old patient (gender not provided) had received unknown dose of FLUZONE HD (No other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.